BCL Law Notes > Oxford BCL Law Notes > Commercial Remedies BCL Notes

Rose Gibb V. Maidstone And Turnbridge Notes

This is a sample of our (approximately) 3 page long Rose Gibb V. Maidstone And Turnbridge notes, which we sell as part of the Commercial Remedies BCL Notes collection, a Distinction package written at Oxford in 2013 that contains (approximately) 523 pages of notes across 153 different documents.

Learn more about our Commercial Remedies BCL Notes

The original file is a 'Word (Docx)' whilst this sample is a 'PDF' representation of said file. This means that the formatting here may have errors. The original document you'll receive on purchase should have more polished formatting.

Rose Gibb V. Maidstone And Turnbridge Revision

The following is a plain text extract of the PDF sample above, taken from our Commercial Remedies BCL Notes. This text version has had its formatting removed so pay attention to its contents alone rather than its presentation. The version you download will have its original formatting intact and so will be much prettier to look at.

ROSE GIBB V. MAIDSTONE

AND

TURNBRIDGE

FACTS Ms Gibb was appointed as Chief Executive of the Trust and as its accountable officer in November 2003. Her contract gave her an entitlement to six months notice of termination - The background to the matter is that in 2006 there were outbreaks of the 'super bug' C.difficile at hospitals managed by the Trust. There was a significant number of deaths and widespread anger and anxiety expressed by relatives of those affected and by others - By 21 September 2007, James Lee, the non-executive Chair of the Trust, had considered the matter with fellow directors and was recording in a letter to the Chairman of the SHA 'while no formal decision has yet been made, we have determined informally that the best course of action would be to encourage, or if necessary force our CEO to step down' - The Committee decided to seek to terminate Ms Gibb's employment by way of a negotiated settlement. Amongst the terms of the agreement, Ms Gibb undertook to accept the immediate termination of her employment; not to pursue any internal grievance or bring any contractual or statutory claim against the Trust; not to make any statement potentially damaging to the Trust; and not to disclose the substance of the Compromise Agreement. On 11 October 2007, Mr Glen Douglas, who had taken over the role of CEO of the Trust, received a letter from David Flory, DirectorGeneral of NHS Finance, Performance and Operations, which instructed Mr Douglas as the accountable officer of the Trust to withhold the severance payment to Rose Gibb until further notice. Subsequently, in 2008, the Department authorised the Trust to make a payment to Ms Gibb in respect of her six month notice period and the sum of approximately £75,000.00 was then paid to Ms Gibb - in this case, she sues for the remaining part of the compensation package. HOLDING The sum of £75,000 odd paid to the appellant (with the blessing of the Department of Health, thus the Secretary of State) was provided for in the compromise agreement to be paid in lieu of due notice to terminate the appellant's contract of employment. Her claim in these proceedings is for the balance of the whole sum of
£250,000 agreed: that is, the sum of £175,000 odd stated to be by way of a compensation payment. That is resisted on the basis, upheld by the judge, that it was ultra vires the Trust to agree the payment: it was "irrationally generous". The Court found that the payment was not ultra vires the trust.

****************************End Of Sample*****************************

Buy the full version of these notes or essay plans and more in our Commercial Remedies BCL Notes.

Related Commercial Remedies Bcl Samples: